Newspaper Advertisement of Audited Financial Results (Standalone and Consolidated) for the quarter and financial year ended March 31, 2025 is attached herewith

pdf

Gufic BioSciences Ltd.

30 May 2025

346.30

-2.66%

Investor Presentation

Gufic Biosciences Ltd - 509079 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

Investor Presentation on Audited Financial Results of the Company for the quarter and financial year ended March 31, 2025 is attached herewith

pdf

Gufic BioSciences Ltd.

30 May 2025

346.30

-2.66%

Company Update

Gufic Biosciences Ltd - 509079 - Announcement under Regulation 30 (LODR)-Updates on Acquisition

BSE India

Intimation for acceptance of equity shares of Gufic Prime Private Limited, Subsidiary Company by way of Right Issue is attached herewith.

pdf

Gufic BioSciences Ltd.

30 May 2025

346.30

-2.66%

Board Meeting

Gufic Biosciences Ltd - 509079 - Board Meeting Outcome for Meeting Held On Friday, May 30, …

BSE India

Pursuant to Regulation 30 read with Part A of Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), we wish to inform that the Board of Directors of the Company at its meeting held today, i.e. Friday, May 30, 2025, inter-alia, considered and approved the matters attached herewith.

pdf

Gufic BioSciences Ltd.

26 May 2025

346.30

-2.66%

Company Update

Gufic Biosciences Ltd - 509079 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

BSE India

Pursuant to Regulation 30 read with Part A of Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform that the Company will host an Earnings Conference Call for Investors/Analysts on Monday, June 02, 2025 at 04:30 p.m. (IST), during which officials of the Company will discuss the business background/prospects and financial performance of the Company and take questions. The details of the Earnings Conference Call are mentioned in the Call Invite which is enclosed herewith.

pdf

Gufic BioSciences Ltd.

23 May 2025, 05:05PM

346.30

-2.66%

Board Meeting

Gufic Biosciences Ltd - 509079 - Board Meeting Intimation for Consideration And Approval Of, Inter Alia, …

BSE India

Gufic Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2025 ,inter alia, to consider and approve 1. Audited Financial Results (Standalone and Consolidated) of the Company for the Quarter and Financial year ended March 31, 2025. 2. Recommend a final dividend, if any, on the equity shares of the Company for the Financial Year 2024-25, subject to approval of shareholders at their ensuing Annual General Meeting

pdf

Gufic BioSciences Ltd.

02 May 2025

346.30

-2.66%

Company Update

Gufic Biosciences Ltd - 509079 - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure …

BSE India

Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Resignation of Cost Auditor is attached herewith.

pdf

Gufic BioSciences Ltd.

18 Apr 2025

346.30

-2.66%

Company Update

Gufic Biosciences Ltd - 509079 - Updation Of Contact Details Of Registrar And Share Transfer Agent …

BSE India

Intimation for Updation of Contact Details of Registrar and Share Transfer Agent ("RTA") of the Company is attached herewith.

pdf

Is Gufic BioSciences Ltd. worth buying?

137 Votes:

Buy 81.75%

Sell 10.22%

Hold 8.03%